durapatite has been researched along with Carcinoma, Hepatocellular in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, T; Hu, Y; Li, Y; Su, Y; Xue, J | 1 |
| Abei, M; Araki, M; Ariungerel, G; Fukuda, K; Hashimoto, T; Hyodo, I; Ishige, K; Ito, A; Kanemoto, A; Mizumoto, M; Numajiri, H; Ohno, T; Okumura, T; Sakae, T; Sakurai, H; Sogo, Y; Tsuboi, K; Zenkoh, J | 1 |
| Cao, X; Dai, H; Han, Y; Li, S; Qiu, T; Wang, X; Wang, Y; Yin, Y; Yuan, L | 1 |
| He, W; Jiang, QC; Li, GP; Lin, SD; Luo, BM; Ou, B; Wu, H; Xu, XL; Yang, HY | 1 |
| Hao, H; Li, Y; Yanhua, W; Zhang, S | 1 |
| Chen, F; Chen, Y; Cheng, B; Feng, M; Wang, G; Wang, S; Wang, Y; Xiong, B; Zhang, C | 1 |
| Ai, X; Chen, X; Dong, S; Huang, Z; Li, G; Liang, H; Qu, J; Sun, Z; Ye, L; Zhang, W | 1 |
| Liu, C; Qian, J; Wang, J; Yuan, Y; Zhang, Y | 1 |
| Dong, S; Guan, J; Li, G; Long, M; Luo, B; Pan, J; Tian, J; Wen, Y; Yang, H; Ye, L; Zhao, Z | 1 |
| Ai, ZL; Liu, ZS; Tang, SL | 1 |
| Bauer, IW; Han, YC; Li, SP; Yin, MZ; Yuan, L | 1 |
| Bauer, IW; Chen, P; Han, YC; Li, SP; Yin, MZ | 1 |
| Holmes, EW; Ii, S; Itakura, M; Iwahana, H; Kudo, E; Mizusawa, N; Oka, J; Yoshimoto, K | 1 |
1 trial(s) available for durapatite and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.
Topics: Adjuvants, Immunologic; Aged; Cancer Vaccines; Carcinoma, Hepatocellular; Combined Modality Therapy; Disease-Free Survival; Durapatite; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mycobacterium bovis; Proton Therapy; Tuberculin; Vaccination | 2013 |
12 other study(ies) available for durapatite and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Studies on the Inhibitory Effects of Nano-Hydroxyapatite-Loaded As₂O₃ on Hepatoma Cells.
Topics: Arsenic Trioxide; Carcinoma, Hepatocellular; Durapatite; Humans; Liver Neoplasms; Nanoparticles; Particle Size | 2020 |
Different inhibitory effect and mechanism of hydroxyapatite nanoparticles on normal cells and cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Durapatite; Endocytosis; Endoplasmic Reticulum; Fibroblasts; Hepatocytes; Humans; Injections, Intralesional; Keratinocytes; Liver Neoplasms; Mice; Mice, Nude; Nanoparticles; Organ Specificity; Osteoblasts; Xenograft Model Antitumor Assays | 2014 |
Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro.
Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Durapatite; Genetic Therapy; Genetic Vectors; Humans; In Vitro Techniques; Liver Neoplasms; Nanoparticles; Polyethyleneimine; RNA, Small Interfering; Transfection | 2015 |
Selenium-substituted hydroxyapatite nanoparticles and their in vivo antitumor effect on hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Durapatite; Humans; Ki-67 Antigen; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Selenium; Spectroscopy, Fourier Transform Infrared; Vascular Endothelial Growth Factor A; X-Ray Diffraction; Xenograft Model Antitumor Assays | 2016 |
Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.
Topics: Aptamers, Nucleotide; Carcinoma, Hepatocellular; Cell Adhesion; Cell Separation; Chitosan; Durapatite; Humans; Liver Neoplasms; Nanostructures; Neoplastic Cells, Circulating; Surface Properties | 2016 |
Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Durapatite; Female; Genes, MDR; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Neoplasms, Experimental; Probability; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2010 |
Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Hepatocellular; Caspases, Initiator; Cell Line, Tumor; Cell Survival; Cytochromes c; Durapatite; Humans; Mitochondria; Nanoparticles; Particle Size; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2010 |
Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Durapatite; Embolization, Therapeutic; Ethiodized Oil; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Therapy; Hep G2 Cells; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Nanoparticles; Necrosis; Rabbits; Time Factors; Transfection; Tumor Burden; Tumor Suppressor Protein p53 | 2012 |
Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Durapatite; Humans; Liver Neoplasms; Nanotechnology; Particle Size; Tumor Cells, Cultured | 2003 |
Internalization of hydroxyapatite nanoparticles in liver cancer cells.
Topics: Carcinoma, Hepatocellular; Clathrin; Coated Pits, Cell-Membrane; Drug Delivery Systems; Durapatite; Humans; Lasers; Liver Neoplasms; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Potassium; Scattering, Radiation; Tumor Cells, Cultured | 2008 |
Effect of hydroxyapatite nanoparticles on the ultrastructure and function of hepatocellular carcinoma cells in vitro.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Durapatite; Humans; Liver Neoplasms; Materials Testing; Nanoparticles; Particle Size | 2006 |
Molecular cloning of human amidophosphoribosyltransferase.
Topics: Amidophosphoribosyltransferase; Amino Acid Sequence; Base Sequence; Blotting, Northern; Blotting, Southern; Carcinoma, Hepatocellular; Chromatography; Chromatography, Affinity; Chromatography, DEAE-Cellulose; Chromatography, Gel; Cloning, Molecular; DNA, Neoplasm; Durapatite; Electrophoresis, Polyacrylamide Gel; Female; Humans; Hydroxyapatites; Liver Neoplasms; Molecular Sequence Data; Molecular Weight; Oligodeoxyribonucleotides; Open Reading Frames; Placenta; Polymerase Chain Reaction; Pregnancy; Tumor Cells, Cultured | 1993 |